Leukapheresis Device Global Market Report 2025

Description

A leukapheresis device is a specialized medical tool designed to selectively isolate and collect white blood cells (leukocytes) from the blood of a patient or donor through centrifugation or filtration methods. It serves an essential function in therapies such as leukemia treatment, stem cell transplantation, and autoimmune disorder management, and is also utilized in clinical research and diagnostic procedures.

The primary categories of leukapheresis devices include therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices. Therapeutic leukapheresis is a medical technique employed to extract surplus or abnormal white blood cells from the bloodstream, aiming to alleviate symptoms or avoid related complications. These systems comprise various elements, including leukapheresis machines, blood collection sets, medical consumables, and filtration components. The diverse group of end users includes hospitals, academic and research organizations, pharmaceutical and biotechnology firms, blood centers, and providers of blood components.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The leukapheresis device market research report is one of a series of new reports from The Business Research Company that provides leukapheresis device market statistics, including the leukapheresis device industry's global market size, regional shares, competitors with the leukapheresis device market share, detailed leukapheresis device market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis device market. This leukapheresis device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis device market size has grown strongly in recent years. It will grow from $0.65 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be credited to the rising demand for personalized medicine, enhanced emphasis on research and development, an increasing number of clinical trials, a growing elderly population, and the expanding adoption of minimally invasive procedures.

The leukapheresis device market size is expected to see strong growth in the next few years. It will grow to $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the rising prevalence of blood-related disorders, increasing incidence of cancer, growing demand for peripheral blood stem cell collection, expanding use of leukapheresis in cellular therapies, and heightened investments in regenerative medicine and immunotherapy. Major trends anticipated during this period include technological innovations in apheresis devices, integration of automation and digital technologies, progress in point-of-care leukapheresis systems, advancements in closed-loop leukapheresis technologies, and technology-enhanced improvements in cell separation efficiency.

The increasing prevalence of blood-related disorders is anticipated to drive the growth of the leukapheresis device market. These disorders affect the structure or function of blood cells, leading to complications with oxygen transport, immune function, and blood clotting. One of the primary reasons for this rise is the aging population, which is more prone to developing conditions such as anemia, leukemia, and other hematologic diseases. Leukapheresis devices play a crucial role in managing these conditions by selectively removing excess or abnormal white blood cells from the bloodstream, thereby easing symptoms and lowering the risk of complications in illnesses like leukemia and autoimmune disorders. For example, in May 2024, the Leukaemia Foundation, an Australian non-profit organization, reported that in 2022, approximately 19,403 Australians were diagnosed with blood cancers, including leukemia, lymphoma, and myeloma. This equates to around 53 new cases each day, or one diagnosis every 27 minutes. Presently, nearly 135,000 Australians are living with a blood cancer or disorder, and projections indicate this number could exceed 275,000 by 2035. This upward trend in blood-related conditions is contributing significantly to the growing demand for leukapheresis devices.

Key players in the leukapheresis device market are increasingly investing in regional production capabilities to improve access to therapeutic devices and align with national healthcare strategies. Establishing local manufacturing facilities helps to streamline supply chains, reduce reliance on imports, and enhance the affordability and availability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, collaborated with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate localized production in Hangzhou. This initiative focuses on producing vital leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely used in China for procedures including therapeutic apheresis, stem cell collection, and blood component separation.

In July 2022, Discovery Life Sciences, a US-based provider of highly characterized human biospecimens, completed the acquisition of AllCells LLC for an undisclosed sum. The acquisition is intended to create a comprehensive, scalable solution offering clients consistent access to high-quality human cellular starting materials along with integrated analytical services to support the development of cell and gene therapies. AllCells LLC, also based in the US, is a biotechnology company that specializes in leukapheresis devices for the targeted collection of blood cells.

Major players in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, and Medica S.p.A.

North America was the largest region in the leukapheresis device market in 2024. The regions covered in leukapheresis device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis device market consists of sales of leukapheresis software and monitoring systems, blood flow controllers and pumps, and centrifuge rotors and tubing sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Device Type: Therapeutic Leukapheresis; Cytapheresis; Stem Cell Collection; Research Applications; Leukapheresis Columns and Cell Separators; Leukapheresis Disposables; Apheresis Devices
2) By Component: Leukapheresis Machine; Blood Collection Set ; Medical Consumables ; Filters
3) By End User: Hospitals; Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Blood Component Providers; Blood Centers
Subsegments:
1) By Therapeutic Leukapheresis: Leukemia Treatment Systems; Sepsis Treatment Leukapheresis Units; Autoimmune Disease Management Devices
2) By Cytapheresis: Plateletpheresis Devices; Lymphapheresis Units; Erythrocytapheresis Systems
3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices; Umbilical Cord Blood Collection Systems; Bone Marrow Stem Cell Apheresis Systems
4) By Research Applications: Cell Separation Systems for Research and Development; Clinical Trial Apheresis Platforms; Academic Laboratory Leukapheresis Devices
5) By Leukapheresis Columns And Cell Separators: Adsorption Columns; Membrane-Based Cell Separation Systems; Centrifugal Cell Separators
6) By Leukapheresis Disposables: Tubing Sets; Needles And Catheters; Collection Bags
7) By Apheresis Devices: Continuous Flow Apheresis Machines; Portable Or Mobile Apheresis Units; Intermittent Flow Apheresis Systems
Companies Mentioned: Fresenius SE and Co. KGaA; Asahi Kasei Medical Co. Ltd; Baxter International Inc.; Grifols S.A.; TERUMO BCT INC.; Kaneka Corporation; Charles River Laboratories International Inc.; Mallinckrodt Pharmaceuticals; Nikkiso Co. Ltd.; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma; Precision for Medicine Inc.; B. Braun Melsungen AG; BioIVT LLC; AllCells LLC; Kawasumi Laboratories Inc.; Beijing Zksk Technology Co. Ltd.; Puriblood Medical Co. Ltd; Medica S.p.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37036

1. Executive Summary

2. Leukapheresis Device Market Characteristics

3. Leukapheresis Device Market Trends And Strategies

4. Leukapheresis Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Device Growth Analysis And Strategic Analysis Framework

5.1. Global Leukapheresis Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Leukapheresis Device Market Growth Rate Analysis
5.4. Global Leukapheresis Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Leukapheresis Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Leukapheresis Device Total Addressable Market (TAM)

6. Leukapheresis Device Market Segmentation

6.1. Global Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutic Leukapheresis
Cytapheresis
Stem Cell Collection
Research Applications
Leukapheresis Columns and Cell Separators
Leukapheresis Disposables
Apheresis Devices
6.2. Global Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukapheresis Machine
Blood Collection Set
Medical Consumables
Filters
6.3. Global Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Academic Research Institutes
Pharmaceutical And Biotechnology Companies
Blood Component Providers
Blood Centers
6.4. Global Leukapheresis Device Market, Sub-Segmentation Of Therapeutic Leukapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukemia Treatment Systems
Sepsis Treatment Leukapheresis Units
Autoimmune Disease Management Devices
6.5. Global Leukapheresis Device Market, Sub-Segmentation Of Cytapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plateletpheresis Devices
Lymphapheresis Units
Erythrocytapheresis Systems
6.6. Global Leukapheresis Device Market, Sub-Segmentation Of Stem Cell Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripheral Blood Stem Cell (Pbsc) Collection Devices
Umbilical Cord Blood Collection Systems
Bone Marrow Stem Cell Apheresis Systems
6.7. Global Leukapheresis Device Market, Sub-Segmentation Of Research Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell Separation Systems For Research And Development
Clinical Trial Apheresis Platforms
Academic Laboratory Leukapheresis Devices
6.8. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Columns And Cell Separators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adsorption Columns
Membrane-Based Cell Separation Systems
Centrifugal Cell Separators
6.9. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Disposables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tubing Sets
Needles And Catheters
Collection Bags
6.10. Global Leukapheresis Device Market, Sub-Segmentation Of Apheresis Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Continuous Flow Apheresis Machines
Portable Or Mobile Apheresis Units
Intermittent Flow Apheresis Systems

7. Leukapheresis Device Market Regional And Country Analysis

7.1. Global Leukapheresis Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Leukapheresis Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Device Market

8.1. Asia-Pacific Leukapheresis Device Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Device Market

9.1. China Leukapheresis Device Market Overview
9.2. China Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Device Market

10.1. India Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Device Market

11.1. Japan Leukapheresis Device Market Overview
11.2. Japan Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Device Market

12.1. Australia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Device Market

13.1. Indonesia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Device Market

14.1. South Korea Leukapheresis Device Market Overview
14.2. South Korea Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Device Market

15.1. Western Europe Leukapheresis Device Market Overview
15.2. Western Europe Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Device Market

16.1. UK Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Device Market

17.1. Germany Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Device Market

18.1. France Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Device Market

19.1. Italy Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Device Market

20.1. Spain Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Device Market

21.1. Eastern Europe Leukapheresis Device Market Overview
21.2. Eastern Europe Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Device Market

22.1. Russia Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Device Market

23.1. North America Leukapheresis Device Market Overview
23.2. North America Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Device Market

24.1. USA Leukapheresis Device Market Overview
24.2. USA Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Device Market

25.1. Canada Leukapheresis Device Market Overview
25.2. Canada Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Device Market

26.1. South America Leukapheresis Device Market Overview
26.2. South America Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Device Market

27.1. Brazil Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Device Market

28.1. Middle East Leukapheresis Device Market Overview
28.2. Middle East Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Device Market

29.1. Africa Leukapheresis Device Market Overview
29.2. Africa Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Device Market Competitive Landscape And Company Profiles

30.1. Leukapheresis Device Market Competitive Landscape
30.2. Leukapheresis Device Market Company Profiles
- 30.2.1. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Device Market Other Major And Innovative Companies

31.1. Kaneka Corporation
31.2. Charles River Laboratories International Inc.
31.3. Mallinckrodt Pharmaceuticals
31.4. Nikkiso Co. Ltd.
31.5. Haemonetics Corporation
31.6. Miltenyi Biotec GmbH
31.7. Macopharma
31.8. Precision for Medicine Inc.
31.9. B. Braun Melsungen AG
31.10. BioIVT LLC
31.11. AllCells LLC
31.12. Kawasumi Laboratories Inc.
31.13. Beijing Zksk Technology Co. Ltd.
31.14. Puriblood Medical Co. Ltd
31.15. Medica S.p.A.

32. Global Leukapheresis Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Device Market

34. Recent Developments In The Leukapheresis Device Market

35. Leukapheresis Device Market High Potential Countries, Segments and Strategies

35.1 Leukapheresis Device Market In 2029 - Countries Offering Most New Opportunities
35.2 Leukapheresis Device Market In 2029 - Segments Offering Most New Opportunities
35.3 Leukapheresis Device Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer